Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LCCC 2044: Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC

NCT04564989 is registered in ClinicalTrials.gov with UNC Lineberger Comprehensive Cancer Center as lead sponsor.

NCT NCT04564989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04564989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LCCC 2044: Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
November 19, 2020
Completion date
November 30, 2033
Enrollment
220 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, squamous cell, head and neck squamous cell carcinoma, oropharyngeal squamous cell carcinoma, oropharynx squamous cell carcinoma